Skip to content

Medtronic Ave Bridge Constant Biliary Stent System

by Medtronic Ave, Inc.

510(k) K030633

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESU Traditional NumberK030633 Date2 Sep 2003ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Medtronic Ave Bridge Constant Biliary Stent System or ('constant
510(k) Number
FDA Product Code
FGE
Device Class
Class II
Regulation
21 CFR Part 876.5010
Advisory Committee
Gastroenterology, Urology
FDA Decision
SESU

Overview

AI-generated summary, 23 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Medtronic Ave Bridge Constant Biliary Stent System is a device intended to maintain patency of a bile duct which is occluded by a malignant tumor. It is constructed of biocompatible materials and delivered via a sheathed delivery system.

The device is supplied as a single-use system and is regulated under FDA 510(k) clearance with product code FGE. It is intended for palliation of malignant neoplasms in the biliary tree and is manufactured by Medtronic Ave, Inc.

Other devices from Medtronic Ave, Inc.

See all devices from Medtronic Ave, Inc. →